Arcadia Biosciences Shares Outstanding vs. Return On Equity

RKDA Stock  USD 6.09  0.31  4.84%   
Based on Arcadia Biosciences' profitability indicators, Arcadia Biosciences may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Arcadia Biosciences' ability to earn profits and add value for shareholders. The current year's Sales General And Administrative To Revenue is expected to grow to 3.02, whereas Price To Sales Ratio is forecasted to decline to 0.69. At present, Arcadia Biosciences' Accumulated Other Comprehensive Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 761.7 K, whereas Operating Income is forecasted to decline to (14.6 M).
For Arcadia Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Arcadia Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Arcadia Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Arcadia Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Arcadia Biosciences over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.
Is Agricultural Products & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.285
Earnings Share
(6.77)
Revenue Per Share
3.802
Quarterly Revenue Growth
(0.04)
Return On Assets
(0.39)
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Arcadia Biosciences Return On Equity vs. Shares Outstanding Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Arcadia Biosciences's current stock value. Our valuation model uses many indicators to compare Arcadia Biosciences value to that of its competitors to determine the firm's financial worth.
Arcadia Biosciences is rated below average in shares outstanding category among its peers. It is rated below average in return on equity category among its peers . At present, Arcadia Biosciences' Return On Equity is projected to drop slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Arcadia Biosciences' earnings, one of the primary drivers of an investment's value.

Arcadia Return On Equity vs. Shares Outstanding

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Arcadia Biosciences

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
1.36 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Arcadia Biosciences

Return On Equity

 = 

Net Income

Total Equity

 = 
-0.53
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Arcadia Return On Equity Comparison

Arcadia Biosciences is currently under evaluation in return on equity category among its peers.

Arcadia Biosciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Arcadia Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Arcadia Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Arcadia Biosciences' change in net profit over the period of time. It can combine multiple indicators of Arcadia Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income116.2 K122 K
Operating Income-13.9 M-14.6 M
Income Before Tax-13.2 M-13.8 M
Total Other Income Expense Net781 K742 K
Net Loss-14 M-14.7 M
Income Tax ExpenseK7.6 K
Net Loss-18.5 M-19.4 M
Net Loss-16.9 M-17.7 M
Interest Income695 K761.7 K
Non Operating Income Net Other7.7 M8.1 M
Net Interest Income704 K739.2 K
Change To Netincome-8.3 M-7.9 M
Net Loss(11.30)(11.87)
Income Quality 1.09  1.01 
Net Income Per E B T 1.06  1.14 

Arcadia Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Arcadia Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Arcadia Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Arcadia Biosciences' important profitability drivers and their relationship over time.

Use Arcadia Biosciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arcadia Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcadia Biosciences will appreciate offsetting losses from the drop in the long position's value.

Arcadia Biosciences Pair Trading

Arcadia Biosciences Pair Trading Analysis

The ability to find closely correlated positions to Arcadia Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arcadia Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arcadia Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arcadia Biosciences to buy it.
The correlation of Arcadia Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arcadia Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arcadia Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arcadia Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Arcadia Biosciences position

In addition to having Arcadia Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Climate Change Thematic Idea Now

Climate Change
Climate Change Theme
Large and medium sized entities that are committing to fully or partially replace some traditional services or products with renewables sources of energy in order to combat global climate change. The Climate Change theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Climate Change Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Arcadia Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcadia Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcadia Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcadia Biosciences Stock:
Check out Your Equity Center.
For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
To fully project Arcadia Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Arcadia Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Arcadia Biosciences' income statement, its balance sheet, and the statement of cash flows.
Potential Arcadia Biosciences investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Arcadia Biosciences investors may work on each financial statement separately, they are all related. The changes in Arcadia Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Arcadia Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.